The Global Veterinary Rapid Tests Market was valued at USD 953.2 million in 2025 and is estimated to grow at a CAGR of 9.1% to reach USD 2.3 billion by 2035.
The market growth is driven by the ongoing shift from centralized diagnostic laboratories toward point-of-care testing across veterinary care environments, including companion animal clinics and livestock field operations. Expanding pet ownership, increasing focus on preventive animal healthcare, and rising demand for fast diagnostic outcomes are further strengthening market adoption. The growing influence of One Health initiatives is also supporting integrated disease monitoring across animals and humans, reinforcing the importance of rapid diagnostic tools. Continuous cost reductions in lateral flow assay technologies are improving affordability and accessibility across developing and developed regions. In addition, advancements in multiplex testing and digital connectivity solutions are enhancing diagnostic accuracy and enabling real-time data sharing. Rising awareness among pet owners and livestock producers regarding early disease detection is further accelerating utilization rates, making veterinary rapid diagnostics a consistently expanding segment within the broader animal health industry.
The rapid test kits segment held 67.6% share in 2025 and is projected to grow at a CAGR of 9.9% through 2035. The dominance of this segment is supported by its recurring consumable demand model, wide clinical applicability across multiple animal diseases, and continuous innovation by manufacturers targeting both companion and livestock health applications. Their ease of use, quick turnaround time, and suitability for on-site testing further strengthen their adoption across veterinary care systems.
The veterinary clinics segment 39.7% share in 2025 and is projected to grow at a CAGR of 8.6% through 2035. This segment leads due to the high concentration of veterinary service providers and the strong reliance on in-clinic diagnostic testing for timely decision-making. Clinics remain the primary access point for animal healthcare services, particularly for companion animals, where rapid testing supports immediate treatment planning and disease management. Increasing demand for point-of-care diagnostics continues to reinforce their central role in veterinary healthcare delivery.
North America Veterinary Rapid Tests Market accounted for 40.5% share in 2025 and is expected to grow at a CAGR of 8.3% through 2035, maintaining its dominant global position. The region’s leadership is supported by high companion animal ownership rates, advanced veterinary care infrastructure, and strong adoption of diagnostic technologies. The United States remains the primary contributor to regional demand, driven by a large base of veterinary practices and increasing emphasis on preventive animal healthcare and early disease detection.
Key market participants include Zoetis, IDEXX Laboratories, Thermo Fisher Scientific, Virbac, Neogen, Heska Corporation (Mars Inc.), BioNote, MEGACOR Diagnostik, Fassisi, Swissavans, INDICAL Bioscience, VetAll Laboratories, BioChek, Agrolabo, and Shenzhen Bioeasy Biotechnology. Companies in the veterinary rapid tests market are strengthening their market position through continuous product innovation focused on improving diagnostic speed, accuracy, and ease of use. Many players are expanding their portfolios with multiplex testing solutions capable of detecting multiple pathogens in a single test. Strategic investments in digital diagnostics and connected platforms are enabling real-time data sharing and enhanced clinical decision-making. Firms are also increasing partnerships with veterinary clinics, laboratories, and distributors to improve market penetration. Expansion into emerging markets with rising pet adoption and livestock populations is another key strategy.
This product will be delivered within 2-4 business days.
The market growth is driven by the ongoing shift from centralized diagnostic laboratories toward point-of-care testing across veterinary care environments, including companion animal clinics and livestock field operations. Expanding pet ownership, increasing focus on preventive animal healthcare, and rising demand for fast diagnostic outcomes are further strengthening market adoption. The growing influence of One Health initiatives is also supporting integrated disease monitoring across animals and humans, reinforcing the importance of rapid diagnostic tools. Continuous cost reductions in lateral flow assay technologies are improving affordability and accessibility across developing and developed regions. In addition, advancements in multiplex testing and digital connectivity solutions are enhancing diagnostic accuracy and enabling real-time data sharing. Rising awareness among pet owners and livestock producers regarding early disease detection is further accelerating utilization rates, making veterinary rapid diagnostics a consistently expanding segment within the broader animal health industry.
The rapid test kits segment held 67.6% share in 2025 and is projected to grow at a CAGR of 9.9% through 2035. The dominance of this segment is supported by its recurring consumable demand model, wide clinical applicability across multiple animal diseases, and continuous innovation by manufacturers targeting both companion and livestock health applications. Their ease of use, quick turnaround time, and suitability for on-site testing further strengthen their adoption across veterinary care systems.
The veterinary clinics segment 39.7% share in 2025 and is projected to grow at a CAGR of 8.6% through 2035. This segment leads due to the high concentration of veterinary service providers and the strong reliance on in-clinic diagnostic testing for timely decision-making. Clinics remain the primary access point for animal healthcare services, particularly for companion animals, where rapid testing supports immediate treatment planning and disease management. Increasing demand for point-of-care diagnostics continues to reinforce their central role in veterinary healthcare delivery.
North America Veterinary Rapid Tests Market accounted for 40.5% share in 2025 and is expected to grow at a CAGR of 8.3% through 2035, maintaining its dominant global position. The region’s leadership is supported by high companion animal ownership rates, advanced veterinary care infrastructure, and strong adoption of diagnostic technologies. The United States remains the primary contributor to regional demand, driven by a large base of veterinary practices and increasing emphasis on preventive animal healthcare and early disease detection.
Key market participants include Zoetis, IDEXX Laboratories, Thermo Fisher Scientific, Virbac, Neogen, Heska Corporation (Mars Inc.), BioNote, MEGACOR Diagnostik, Fassisi, Swissavans, INDICAL Bioscience, VetAll Laboratories, BioChek, Agrolabo, and Shenzhen Bioeasy Biotechnology. Companies in the veterinary rapid tests market are strengthening their market position through continuous product innovation focused on improving diagnostic speed, accuracy, and ease of use. Many players are expanding their portfolios with multiplex testing solutions capable of detecting multiple pathogens in a single test. Strategic investments in digital diagnostics and connected platforms are enabling real-time data sharing and enhanced clinical decision-making. Firms are also increasing partnerships with veterinary clinics, laboratories, and distributors to improve market penetration. Expansion into emerging markets with rising pet adoption and livestock populations is another key strategy.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2025
Chapter 5 Market Estimates and Forecast, by Product Type, 2022 - 2035 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Test Type, 2022 - 2035 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Application, 2022 - 2035 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Animal Type, 2022 - 2035 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Sample Type, 2022 - 2035 ($ Mn)
Chapter 10 Market Estimates and Forecast, by End Use, 2022 - 2035 ($ Mn)
Chapter 11 Market Estimates and Forecast, by Region, 2022 - 2035 ($ Mn)
Chapter 12 Company Profiles
Companies Mentioned
- Zoetis
- IDEXX Laboratories
- Thermo Fisher Scientific
- Virbac
- Neogen
- Heska Corporation (Mars Inc.)
- BioNote
- MEGACOR Diagnostik
- Fassisi
- Swissavans
- INDICAL Bioscience
- VetAll Laboratories
- BioChek
- Agrolabo
- Shenzhen Bioeasy Biotechnology
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | June 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 953.2 Million |
| Forecasted Market Value ( USD | $ 2300 Million |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
